Exhibit 10.1
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
ADVISORY SERVICES AGREEMENT
This Advisory Services Agreement (this “Agreement”) is effective June 14, 2023 (the “Effective Date”) by and between Oncternal Therapeutics, Inc., a Delaware corporation (“Oncternal”) and Gunnar F. Kaufmann, Ph.D. (“Advisor”), to state the terms under which Advisor shall perform services for Oncternal.
1
2
3
4
5
6
7
8
[Signature Page Follows]
9
The parties have executed this Agreement as of the date below.
Oncternal Therapeutics, Inc.
By:/s/James B. Breitmeyer, M.D. Ph.D.
Name: James B. Breitmeyer, M.D., Ph.D.
Title: Chief Executive Officer
Date: June 14, 2023
Address: 12230 El Camino Real, Suite 230
San Diego, CA 92130
Email: [***]
Advisor
By:/s/Gunnar F. Kaufmann
Name: Gunnar F. Kaufmann
Address: [***]
Email: [***]
Signature Page to Advisory Services Agreement
Exhibit A
Services
Advisor shall [***]. In connection with such service, Advisor shall:
Compensation